Iovance Biotherapeutics, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Iovance Biotherapeutics, Inc.
RECRUITINGPhase 2NCT07288203
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
This is a Phase 2, multicenter, open-label study of lifileucel (tumor-infiltrating lymphocytes \[TIL\]) in participants with previously treated advanced melanoma
Sponsor: Iovance Biotherapeutics, Inc.Enrolling: 1005 locations
Melanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma
RECRUITINGPhase 1NCT06566092
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
This study is planned to test the safety and tolerability of the TIL regimen. The study will also test how well TIL fights cancer. The study will enroll children, teenagers, and...
Sponsor: Iovance Biotherapeutics, Inc.Enrolling: 405 locations
Soft Tissue SarcomaPrimary Central Nervous System CarcinomaMelanoma+2